Patrick James Orme

Array ( [id] => 6142152 [patent_doc_number] => 20110129461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'Mat II Beta Subunit RNAi and Therapeutic Methods Using Same' [patent_app_type] => utility [patent_app_number] => 12/936780 [patent_app_country] => US [patent_app_date] => 2009-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 33695 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20110129461.pdf [firstpage_image] =>[orig_patent_app_number] => 12936780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5526854 [patent_doc_number] => 20090196931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'THERAPEUTIC INHIBITOR OF VASCULAR SMOOTH MUSCLE CELLS' [patent_app_type] => utility [patent_app_number] => 12/418209 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 40502 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20090196931.pdf [firstpage_image] =>[orig_patent_app_number] => 12418209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6496432 [patent_doc_number] => 20100010071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'Compositions and use of EPAS1 inhibitors' [patent_app_type] => utility [patent_app_number] => 12/384475 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27319 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20100010071.pdf [firstpage_image] =>[orig_patent_app_number] => 12384475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7527601 [patent_doc_number] => 08044193 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Short interfering RNAs targeted to T-LAK cell-originated protein kinase (TOPK) polynucleotide' [patent_app_type] => utility [patent_app_number] => 12/416900 [patent_app_country] => US [patent_app_date] => 2009-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 36345 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/044/08044193.pdf [firstpage_image] =>[orig_patent_app_number] => 12416900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539881 [patent_doc_number] => 20090221686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Modulation of the Transcription of Pro-Inflammatory Gene Products' [patent_app_type] => utility [patent_app_number] => 12/411926 [patent_app_country] => US [patent_app_date] => 2009-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8366 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221686.pdf [firstpage_image] =>[orig_patent_app_number] => 12411926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9427653 [patent_doc_number] => 08703729 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene' [patent_app_type] => utility [patent_app_number] => 12/382415 [patent_app_country] => US [patent_app_date] => 2009-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3705 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12382415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5355504 [patent_doc_number] => 20090186848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'ANTISENSE ANTIVIRAL COMPOUNDS AND METHODS FOR TREATING A FILOVIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 12/402461 [patent_app_country] => US [patent_app_date] => 2009-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 17843 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186848.pdf [firstpage_image] =>[orig_patent_app_number] => 12402461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5355503 [patent_doc_number] => 20090186847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'ANTISENSE ANTIVIRAL COMPOUNDS AND METHODS FOR TREATING A FILOVIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 12/402455 [patent_app_country] => US [patent_app_date] => 2009-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 17769 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186847.pdf [firstpage_image] =>[orig_patent_app_number] => 12402455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5355505 [patent_doc_number] => 20090186849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'ANTISENSE ANTIVIRAL COMPOUNDS AND METHODS FOR TREATING A FILOVIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 12/402464 [patent_app_country] => US [patent_app_date] => 2009-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 17838 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186849.pdf [firstpage_image] =>[orig_patent_app_number] => 12402464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016949 [patent_doc_number] => 20110224279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'ANTICANCER AGENT' [patent_app_type] => utility [patent_app_number] => 12/920167 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15494 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224279.pdf [firstpage_image] =>[orig_patent_app_number] => 12920167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6032775 [patent_doc_number] => 20110055965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'CYCLE SINGLE-STRANDED NUCLEIC ACID COMPLEX AND METHOD FOR PRODUCING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/867090 [patent_app_country] => US [patent_app_date] => 2009-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7362 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20110055965.pdf [firstpage_image] =>[orig_patent_app_number] => 12867090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436133 [patent_doc_number] => 20090170720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF JOINT DEGENERATIVE AND INFLAMMATORY DISEASES' [patent_app_type] => utility [patent_app_number] => 12/360332 [patent_app_country] => US [patent_app_date] => 2009-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 31063 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170720.pdf [firstpage_image] =>[orig_patent_app_number] => 12360332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558910 [patent_doc_number] => 20090270487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'Compositions and methods for inhibiting the synthesis or expression of MMP-1' [patent_app_type] => utility [patent_app_number] => 12/352214 [patent_app_country] => US [patent_app_date] => 2009-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12591 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270487.pdf [firstpage_image] =>[orig_patent_app_number] => 12352214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367239 [patent_doc_number] => 20090304798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Methods and compositions for therapeutic use of RNA interference' [patent_app_type] => utility [patent_app_number] => 12/319711 [patent_app_country] => US [patent_app_date] => 2009-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24657 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304798.pdf [firstpage_image] =>[orig_patent_app_number] => 12319711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016943 [patent_doc_number] => 20110224277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs' [patent_app_type] => utility [patent_app_number] => 12/346919 [patent_app_country] => US [patent_app_date] => 2008-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 136620 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224277.pdf [firstpage_image] =>[orig_patent_app_number] => 12346919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5490836 [patent_doc_number] => 20090291907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs' [patent_app_type] => utility [patent_app_number] => 12/345891 [patent_app_country] => US [patent_app_date] => 2008-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 136643 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291907.pdf [firstpage_image] =>[orig_patent_app_number] => 12345891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5490835 [patent_doc_number] => 20090291906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs' [patent_app_type] => utility [patent_app_number] => 12/345854 [patent_app_country] => US [patent_app_date] => 2008-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 136623 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291906.pdf [firstpage_image] =>[orig_patent_app_number] => 12345854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8177436 [patent_doc_number] => 08178506 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-15 [patent_title] => 'Oligomeric compounds and compositions for use in modulation of small non-coding RNAs' [patent_app_type] => utility [patent_app_number] => 12/345780 [patent_app_country] => US [patent_app_date] => 2008-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 136597 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/178/08178506.pdf [firstpage_image] =>[orig_patent_app_number] => 12345780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5380274 [patent_doc_number] => 20090192113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Interfering RNA Duplex Having Blunt-Ends and 3`-Modifications' [patent_app_type] => utility [patent_app_number] => 12/338601 [patent_app_country] => US [patent_app_date] => 2008-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6464 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192113.pdf [firstpage_image] =>[orig_patent_app_number] => 12338601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6466810 [patent_doc_number] => 20100040576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'Modified Oligonucleotides For The Treatment Of Hepatitis C Infection' [patent_app_type] => utility [patent_app_number] => 12/336223 [patent_app_country] => US [patent_app_date] => 2008-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5585 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20100040576.pdf [firstpage_image] =>[orig_patent_app_number] => 12336223 [rel_patent_id] =>[rel_patent_doc_number] =>)